FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

First-Graders Leap Into Action and Save Their Teacher from Choking in Virginia Classroom

GOP Rep Goes Nuclear After Democrat Cuts Him Off Mid-Sentence: ‘You Were That Rude’

Widespread Obamacare Fraud: Phony SSNs Had a 100% Success Rate for Getting Coverage, Investigation Finds

How Is This Not Racist? Ex-MSNBC Host Trashes Minorities for Working with ICE to Catch Criminals

Florida teens in custody after 14-year-old girl found shot to death, burnt: sheriff

Alaska school district erases Veterans Day from official calendar: ‘Absolutely unacceptable’

Tom Homan Nukes Heckler Who Calls Him Traitor: ‘Grow A Backbone, Put a Kevlar Vest and a Gun on’

Public School Students Allowed to Skip Classes in Chicago if They ‘Fear’ ICE

Congress faces holiday crunch as health care fix collides with shrinking calendar

Republicans divided over whether to salvage Obamacare — or replace it — ahead of subsidy deadline

GOP stands firm in ‘blue slip’ battle with Trump despite prosecutor setbacks

Idaho bar owner faces death threats after viral promo offering free beer for assisting ICE

Judge rules evidence linked to James Comey’s ally is off limits to DOJ

EXCLUSIVE: Trump-led Kennedy Center nearly doubles fundraising from Biden era, smashing record with $23M haul

Hegseth hints at major defense spending hike, reveals new details on Trump’s anti-narco-terrorism operations

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”